BioCentury
ARTICLE | Clinical News

CHMP backs TiGenix's Alofisel for Crohn's

December 22, 2017 12:14 AM UTC

EMA's CHMP recommended approval of Alofisel darvadstrocel (Cx601) from TiGenix N.V. (Euronext:TIG; NASDAQ:TIG) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to treat complex perianal fistulas in p...